Abstract
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Neuropsychopharmacology |
Vol/bind | 9 |
Udgave nummer | 4 |
Sider (fra-til) | 351-9 |
Antal sider | 8 |
ISSN | 0924-977X |
Status | Udgivet - 1999 |
Udgivet eksternt | Ja |
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain. / Smith, D F; Gee, A D; Hansen, Søren Baarsgaard; Moldt, P; Nielsen, E Ø; Scheel-Krüger, J; Gjedde, A.
I: European Neuropsychopharmacology, Bind 9, Nr. 4, 1999, s. 351-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Uptake and distribution of a new SSRI, NS2381, studied by PET in living porcine brain.
AU - Smith, D F
AU - Gee, A D
AU - Hansen, Søren Baarsgaard
AU - Moldt, P
AU - Nielsen, E Ø
AU - Scheel-Krüger, J
AU - Gjedde, A
PY - 1999
Y1 - 1999
N2 - This study tests the utility of a new selective serotonin reuptake inhibitor (SSRI), [11C]NS2381 {(+/-)-(8-[11C]methyl-3-(4-trifluoromethyl-phenyl)-8-azabicyclo[3.2.1]oc t-2-ene)}, as positron-emitting radioligand for labelling serotonin (5-HT) reuptake sites in living brain. Studies of monoamine uptake were carried out initially in vitro using rat brain synaptosomes. They showed that NS2381 and its precursor NS2435 are selective inhibitors of serotonin (5-HT) uptake. Then, studies were carried out in vivo on the uptake and distribution of [11C]NS2381 in living porcine brain. They showed that the radiotracer accumulates readily in brain, and binds reversibly in regions rich in serotonin uptake sites (e.g. raphe, basal ganglia and thalamus). In addition, [11C]NS2381 was displaced from brain tissue by the potent SSRI citalopram. The enantiomers of [11C]NS2381 were, in general, found to be similar to the racemate in terms of their uptake and distribution in living pig brain. Thus, [11C]NS2381 fulfilled several criteria of a PET radioligand for studying 5-HT uptake sites in the living brain.
AB - This study tests the utility of a new selective serotonin reuptake inhibitor (SSRI), [11C]NS2381 {(+/-)-(8-[11C]methyl-3-(4-trifluoromethyl-phenyl)-8-azabicyclo[3.2.1]oc t-2-ene)}, as positron-emitting radioligand for labelling serotonin (5-HT) reuptake sites in living brain. Studies of monoamine uptake were carried out initially in vitro using rat brain synaptosomes. They showed that NS2381 and its precursor NS2435 are selective inhibitors of serotonin (5-HT) uptake. Then, studies were carried out in vivo on the uptake and distribution of [11C]NS2381 in living porcine brain. They showed that the radiotracer accumulates readily in brain, and binds reversibly in regions rich in serotonin uptake sites (e.g. raphe, basal ganglia and thalamus). In addition, [11C]NS2381 was displaced from brain tissue by the potent SSRI citalopram. The enantiomers of [11C]NS2381 were, in general, found to be similar to the racemate in terms of their uptake and distribution in living pig brain. Thus, [11C]NS2381 fulfilled several criteria of a PET radioligand for studying 5-HT uptake sites in the living brain.
M3 - Journal article
C2 - 10422897
VL - 9
SP - 351
EP - 359
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
SN - 0924-977X
IS - 4
ER -